Classical Swine Fever Vaccine

Indian Immunologicals Raksha-Class CSF vaccine is indicated to prevent or reduce the severity of the CSF infection in pigs.

Target Species: Specifically developed for use in domestic pigs.
Disease Prevention: It is used to prevent infection by the Classical Swine Fever Virus (CSFV), a highly contagious and often fatal viral disease that causes significant economic losses in the swine industry.
Technology: It is a live attenuated vaccine produced using cell culture technology. This technology allows for mass production to meet high demand in endemic regions like India.
Efficacy & Safety: The vaccine is tested for safety, sterility, and potency to ensure it effectively reduces mortality rates and prevents the spread of the virus within herds.
Strategic Use: It is primarily indicated for use in areas where CSF is endemic to help increase the pig population and protect the livelihoods of pig growers.

Method: The vaccine is administered via intramuscular injection.
Location: The injection is given in the neck, behind the ear.
Dosage: The standard dose is 2 mL per pig.
Frequency:
- Piglets: A first vaccination between 30 to 35 days old, followed by a second at 60 to 65 days old is a common schedule.
- Sows: Typically vaccinated 3 weeks before farrowing.
- Boars: May require an injection every 6 months.

Benefits of the vaccine

Safety: The vaccine has undergone testing for safety, sterility, and potency.
Immunity: It provides active immunization to protect pigs against various strains of the CSF virus.
Scalability: The vaccine is developed to be scaled up in cell cultures to meet the country’s demand, making it suitable for mass vaccination programs.
Potential for Long-Term Immunity: Some reports on similar cell culture vaccines suggest they may provide up to two years of immunity, compared to 3 to 6 months for older vaccines.